000			01829 a2200469 4500
005			20250513202301.0
264		0	_c20000301
008			200003s 0 0 eng d
022			_a0167-8140
024	7		_a10.1016/s0167-8140(99)00145-0 _2doi
040			_aNLM _beng _cNLM
100	1		_aGershkevitsh, E
245	0	0	_aBone marrow doses and leukaemia risk in radiotherapy of prostate cancer. _h[electronic resource]
260			_bRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology _cDec 1999
300			_a189-97 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aBone Marrow _xradiation effects
650	0	4	_aDecision Making
650	0	4	_aDose Fractionation, Radiation
650	0	4	_aHumans
650	0	4	_aLeukemia, Myeloid, Acute _xetiology
650	0	4	_aLeukemia, Radiation-Induced _xetiology
650	0	4	_aLumbar Vertebrae _xradiation effects
650	0	4	_aMale
650	0	4	_aNeoplasms, Second Primary _xetiology
650	0	4	_aPatient Care Planning
650	0	4	_aPelvic Bones _xradiation effects
650	0	4	_aPhantoms, Imaging
650	0	4	_aProstatic Neoplasms _xradiotherapy
650	0	4	_aRadiotherapy Dosage
650	0	4	_aRadiotherapy Planning, Computer-Assisted
650	0	4	_aRadiotherapy, Conformal
650	0	4	_aRectum _xradiation effects
650	0	4	_aRisk Factors
650	0	4	_aThermoluminescent Dosimetry
650	0	4	_aTomography, X-Ray Computed
700	1		_aRosenberg, I
700	1		_aDearnaley, D P
700	1		_aTrott, K R
773	0		_tRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology _gvol. 53 _gno. 3 _gp. 189-97
856	4	0	_uhttps://doi.org/10.1016/s0167-8140(99)00145-0 _zAvailable from publisher's website
999			_c10615116 _d10615116